DIALYSIS · CCN 852604
DaVita Bellemeade Dialysis
Smyrna, GA 30080
DialysisProfitDaVita
$3.0M
TOTAL REVENUE
25.4%
OPERATING MARGIN
3 / 5
STAR RATING
11
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL
Cost report financials (FY2025)
- Net patient revenue
- $3.0M
- Total costs
- $2.2M
- Operating income (rev − costs)
- $753K
- Operating margin
- 25.4%
- Total charges
- $2.9M
- Total treatments
- 5,727
- Dialysis stations
- 17
Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.
02 — QUALITY MEASURES
11 quality measures
| Measure | Score | Denominator | Period |
|---|---|---|---|
Standardized ED Visits Within 30 Days of Hospital Discharge DFC_ED30 | 0 | 13 | — |
Fistula Rate DFC_FISTULA_RATE | 56.4 | 42 | — |
Five Star Rating DFC_FIVE_STAR | 3 | — | — |
Healthcare Worker COVID-19 Vaccination Adherence DFC_HCP_VACC | 0 | — | — |
Patient Hospitalization Rate DFC_HOSPITALIZATION_RATE | 132.2 | 26 | — |
Standard Infection Ratio (SIR) DFC_INFECTION_RATIO | 0 | — | — |
Percentage of Adult Patients with Long Term Catheter in Use DFC_LONG_CATHETER | 20 | 42 | — |
Patient Survival (Mortality Rate) DFC_MORTALITY_RATE | 12 | 34 | — |
Percentage of Prevalent Patients Waitlisted for Kidney Transplant DFC_PPPW | 6.1 | 42 | — |
Patient Hospital Readmission Rate DFC_READMISSION_RATE | 17.8 | 25 | — |
Standardized ED Visits Ratio DFC_SEDR | 0.61 | 12 | — |